2016 Initial Public Offering Negotiation 
Cooley M&A
JANUARY 25, 2023
Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.
Cooley M&A
SEPTEMBER 16, 2022
The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. The risk tolerance of the high-vote stockholder and the dual-class company’s board. 11, 101-147, available at [link]. [11]
Expert insights. Personalized for you.
40 
Let's personalize your content